Table 1. In Vitro Susceptibilities of Streptococcus pyogenes to Common Antibiotics
Antibiotic |
MIC50 (μg/mL) |
MIC90 (μg/mL) |
Range (μg/mL) |
Reference |
Penicillin |
0.006 |
0.012 |
0.003 - 0.024 |
|
Oxacillin |
0.06 |
0.06 |
≤0.03 - 0.25 |
|
Erythromycin |
0.016 |
0.031 |
0.0078 - 8.0 |
|
Azithromycin |
0.016 |
0.031 |
0.0078 - 4.0 |
|
Clarithromycin |
0.0078 |
0.016 |
0.0039 - 4.0 |
|
Cephalothin |
0.1 |
0.1 |
0.0125 - 0.2 |
|
Cefoxitin |
1 |
1 |
1 - 4 |
|
Cefixime |
0.25 |
0.5 |
0.078 - 0.5 |
|
Cefuroxime |
≤0.03 |
≤0.03 |
≤0.03 |
|
Cefotaxime |
≤0.03 |
≤0.03 |
≤0.03 |
|
Ceftriaxone |
≤0.03 |
≤0.03 |
≤0.03 - 0.125 |
|
Vancomycin |
0.25 |
0.5 |
0.25 - 0.5 |
|
Clindamycin |
0.125 |
0.125 |
0.06 - 0.125 |
|
Rifampin |
0.5 |
0.5 |
≤0.03 - 0.5 |
|
Ciprofloxacin |
0.256 |
0.5 |
0.016 - 2.0 |
|
Tetracycline |
0.25 |
2 |
0.0039 - 8.0 |
|
Cotrimoxazole |
≥64 |
≥64 |
≥64 |
|
Chloramphenicol |
4 |
4 |
2 - 8 |
Table 2. Suggested
Antibiotics, Doses and Duration For Treatment of Streptococcus pyogenes
Infections
|
Suggested Therapy |
||
Infection Type |
Primary |
Alternative |
Duration |
|
|
|
|
Pharyngitis |
Penicillin Amoxicillin |
Erythromycin Clindamycin |
10 days
|
Soft tissue Cellulitis |
Dicloxicillin Cephalexin |
Clindamycin Erythromycin |
10 days 14 days |
Impetigo Erysipelas |
Penicillin |
Erythromycin Clindamycin |
10 days |
Necrotizing fasciitis |
Nafcillin plus Clindamycin |
Vancomycin plus Clindamycin |
14 days |
Myositis |
Nafcillin plus Clindamycin (*add Clindamycin if toxic patient) |
Vancomycin Cefazolin |
10-14 days |
Lymphangitis |
Dicloxicillin Cefazolin |
Clindamycin Vancomycin |
10 days |
Puerperal sepsis |
Clindamycin plus Gentamicin |
Cefoxitin |
10 days |
Vulvovaginits |
Penicillin Amoxicillin |
Cephalexin Erythromycin |
10 days |
Omphalitis |
Ampicillin-Sulbactam |
Vancomycin Clindamycin |
10 days |
Streptococcal Toxic Shock Syndrome |
Nafcillin plus Clindamycin |
Vancomycin plus Clindamycin |
10 – 14 days |
Bacteremia |
Penicillin Ampicillin |
Cefazolin Vancomycin |
10 – 14 days |
Pneumonia |
Penicillin Ampicillin |
Clindamycin Cefazolin Vancomycin |
10 – 14 days |
Peritonsillar Abscess or Cellulitis |
Clindamycin Ampicillin-Clavulanic Acid |
Cefazolin |
10 days |
Retropharyngeal Abscess |
Ampicillin-Sulbactam Penicillin plus Clindamycin |
|
14 days |
Meningitis |
Nafcillin plus Clindamycin |
Vancomycin plus Clindamycin |
10 – 14 days |
Endocarditis |
Penicillin Ampicillin |
|
4-6 weeks |
Osteomyelitis |
Penicillin Nafcillin |
Clindamycin Cefazolin Vancomycin |
21 days |
IV Doses:
Ampicillin 2 gm IV q 6° Gentamicin 2 mg/kg IV q 8°
Ampicillin-Sulbactam 2 gm (of Amp) IV q 6° Nafcillin 2.0 gm q 4° IV
Cefazolin 2.0 gm q 8° IV Penicillin G 1-4 million units IV q 6°
Cefoxitin 2 gm IV q 6° Vancomycin 1.0 gm q 12° IV
Clindamycin 900 mg q 8° IV
Oral Doses:
Amoxicillin 500 mg p.o. bid Dicloxicillin 500 mg p.o. qid
Amoxicillin-Clavulanic Acid 875 mg p.o. bid Erythromycin 150-250 mg p.o. tid
Cephalexin 250-500 mg p.o. qid Penicillin V 500 mg p.o. bid
Clindamycin 300 mg p.o. qid